Loading clinical trials...
Loading clinical trials...
The goal of this clinical trial is to learn if probiotics can improve symptoms and quality of life in participants with Long COVID.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Rush University Medical Center
NCT07189936 · Post-Acute COVID-19 Syndrome, Postural Tachycardia Syndrome (POTS), and more
NCT04806620 · Post-Acute COVID-19 Syndrome, ME/CFS, and more
NCT05421208 · Post-acute COVID-19 Syndrome, Postural Tachycardia Syndrome (POTS), and more
NCT05926505 · Post-Acute COVID-19 Syndrome, Post-Acute COVID-19, and more
NCT06590324 · Post-Acute COVID-19 Syndrome
Rush University Medical Center
Chicago, Illinois
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions